Rupatadine oral solution for 2-5-year-old children with allergic rhinitis: a safety, open-label, prospective study

about

Rupatadine oral solution for 2-5-year-old children with allergic rhinitis: a safety, open-label, prospective study

Item

http://www.wikidata.org/entity/Q58765003

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 04 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Rupatadine oral solution for 2 ...... open-label, prospective study

@en

Rupatadine oral solution for 2 ...... open-label, prospective study

@nl

type

Item

label

Rupatadine oral solution for 2 ...... open-label, prospective study

@en

Rupatadine oral solution for 2 ...... open-label, prospective study

@nl

prefLabel

Rupatadine oral solution for 2 ...... open-label, prospective study

@en

Rupatadine oral solution for 2 ...... open-label, prospective study

@nl

P1476

Rupatadine oral solution for 2 ...... open-label, prospective study

@en

P2093

Eva Santamaría

http://www.w3.org/2001/XMLSchema#string

Iñaki Izquierdo

http://www.w3.org/2001/XMLSchema#string

Jan Vermeulen

http://www.w3.org/2001/XMLSchema#string

Paul Potter

http://www.w3.org/2001/XMLSchema#string

P2860

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

BSACI guidelines for the management of allergic and non-allergic rhinitis.

Rhinitis in children less than 6 years of age: current knowledge and challenges.

Impact of allergic rhinitis in school going children.

Update on rupatadine in the management of allergic disorders.

Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis.

The Paris prospective birth cohort study: which design and who participates?

Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months.

Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.

The influence of gender and atopy on the natural history of rhinitis in the first 18 years of life.

P304

225-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JAA.S164632

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marta Valle

P577

2018-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30214250

http://www.w3.org/2001/XMLSchema#string

P932

6128281

http://www.w3.org/2001/XMLSchema#string